Treatment for Scleroderma-related Interstitial Lung Disease

Wendy Henderson avatar

by Wendy Henderson |

Share this article:

Share article via email


Scleroderma is a chronic autoimmune disease that can attack various organs of the body. Many patients with scleroderma have interstitial lung diseases (ILDs). ILDs cause scarring of the lungs which makes breathing very difficult and life-threatening.

Read about a clinical trial for a promising therapy for systemic scleroderma patients with interstitial lung disease. 

In this webinar from SRFCure, rheumatologist and co-director of the UCLA Connective Tissue Research Program, Dr. Elizabeth Volkmann, discusses scleroderma-related interstitial lung disease (SSc-ILD). Listen as she focusing on treatment options, long-term outcomes, and the results of clinical studies.

Read about a potential serum biomarker for interstitial lung disease associated with scleroderma.

Scleroderma News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.